Mirtazapina Aurobindo (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapina Aurobindo, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It treats major depressive disorder in adult patients. GNH USA supplies Mirtazapina Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mirtazapine is indicated for depressive disorders and works by modulating noradrenergic and serotonergic pathways.

Major depressive disorder: reduces depressive symptoms and improves mood and sleep quality.

Mirtazapine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth - Constipation - Dizziness - Orthostatic hypotension

Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Seizures - Hyponatremia - Severe hepatic dysfunction

Before prescribing mirtazapine, clinicians should consider several safety aspects. - Assess hepatic function: adjust dose if liver impairment is present. - Monitor for suicidal ideation: especially during early treatment. - Use caution in elderly: higher risk of sedation and falls. - Avoid abrupt discontinuation: taper to reduce withdrawal symptoms. - Adjust dose in renal impairment: consider reduced clearance. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Mirtazapine can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Strong CYP2D6 inhibitors (e.g., fluoxetine): may increase mirtazapine plasma levels. - Other serotonergic agents (e.g., tramadol, triptans): potential serotonin syndrome.

Moderate Interactions (Monitor Closely): - Alcohol: additive central nervous system depression. - Antihistamines: increased sedation. - CNS depressants (e.g., benzodiazepines): enhanced drowsiness and impaired coordination.